Inspiring Dry Powder Inhalation

SESSION 8: Powders that Perform:
Next-Generation DPI Therapies

Wednesday • May 13, 2026 • 3:30–5:00 PM • Trailblazer’s Ballroom
Moderator: Paul M. Young, Ph.D.

From Concept to Commercialization: Scaling the Print® Particle Platform For High Dose Treprostinil Delivery
Derek Schorzman
Liquidia Technologies
Exploring Aerosolized Powder Behavior in Dry Powder Inhalers using Advanced Imaging Techniques
Susan Boc
U.S. Food & Drug Administration
Electrostatic Effects on Inhaled Aerosol Deposition in the Deep Pulmonary Airways
Ron Bessler
Technion - Israel Institute of Technology

Discover More

Prepare for Launch: Ensuring your Spray-Dried Inhalation Product is Commercial Ready
Alan Watts
Catalent
Winning the Hand You’re Dealt: An Interactive Workshop on Developing Innovative Spray-Dried Products
Kimberly Shepard
Lonza
Development and Characterization of Inhalable Microparticles Co-Delivering Nintedanib and Metformin for Idiopathic Pulmonary Fibrosis
Tingting Shi and Yuqing Ye
Eastern Institute of Technology
In Vitro Performance of a Mannitol-Based Spray-Dried Powder Combined with Quattrii Carrier Free Dry Powder Inhaler
Irene Rossi
Harro Höfliger
In Vitro Performance Assessment of Fluticasone Propionate/Salmeterol Xinafoate Blends Developed for a Capsule-Based Device
Irene Rossi
Harro Höfliger
Screening of Capsule-Filling Process Parameters in the Development of Spray-Dried Powder Products for Pulmonary Delivery
Marian Asch and Rui Alberto Teixeira Cruz
Harro Höfliger
Determining Material Composition of Fines-Only Formulations Through X-Ray Computed Tomography
Parmesh Gajjar and Darragh Murnane
InformiX Pharma
Design of Spray-Dried Glucagon-Like Peptide-1 Exenatide Microparticles for Pulmonary Delivery: A Room-Temperature Stable Formulation of an Oxidation Sensitive Peptide
Keith Ung
Kindeva
Powder Rheology for Batch Comparison During Manufacturing
Ken Lo
Lonza
Excipient Effects on Spray-Dried Antibody Stability: A Comparative Study
Adam Schneiderhan and Beatriz Fernandes
Lonza
Replacing Sugar Excipient with Polymyxins to Improve Dosing of a Dry Powder Teixobactin-Lipopeptide Hybrid for the Treatment of Pulmonary Infections
Sara Maloney Norcross
RTI International
Optimization of Spray-Dried Spectinamide Lee1810 Inhalation Powders
Erik Pena and Sara Maloney Norcross
RTI International
Development and Evaluation of Inhalable Imipenem Dry Powder for Treating Pulmonary Pseudomonas aeruginosa Infections
Parasharamulu Kommarajula
St. John's University
A Distribution-Based Metric for Quantifying Dispersibility in Dry Powder Inhalers
Grace Xia
University of Michigan
Development of PEGylated DNase for Nebulization
Francesca Buttini
University of Parma
Influence of L-Leucine Content on the Internal and External Morphology of Spray-Dried Particles
Jordan Potts
Upperton Pharma Solutions
Tobramycin-Synthetic Lung Surfactant Dry Powder for Treatment of Pseudomonas aeruginosa-Induced Lung Infection in Rats
Rudra Pangeni
Virginia Commonwealth University
Achieving Improved Lung Delivery of Synthetic Lung Surfactant Excipient Enhanced Growth Dry Powder Aerosol Formulations in Neonates
Mohammad Momin
Virginia Commonwealth University
PEGylated Ciprofloxacin Liposomal Dry Powder: Efficacy in Acute Rat Pseudomonas aeruginosa-Induced Lung Infection
Surendra Poudel
Virginia Commonwealth University
Impact of Spray-Dryer Technology on the Aerosol Performance and Physicochemical Properties of Synthetic Dipalmitoylphosphatidylcholine Dry Powder Formulations
Baiwei Chen
Virginia Commonwealth University
Development of an Inhalation-Assisted Pediatric Dry Powder Inhaler and Synthetic Lung Surfactants Excipient Enhanced Growth Platform for Anti-Infective Aerosol Delivery
Riley Schweizer
Virginia Commonwealth University
Investigating Effects of Single Prong Nasal Interface Orifice Diameter and Capillary-to-Orifice Distance on Air Jet Dry Power Inhaler Plume Properties and Performance
Caleb Dalton
Virginia Commonwealth University
CONFERENCE SUPPORTERS
WORKSHOP PRESENTERS
EXHIBITORS
↑ Back to Top